NFKB2 and gastric cancer: GC patients with high expression of NFKB2, REL, RELA, and RELB possessed a significantly shorter OS and first progression (FP) than patients with low expression of these four genes, while similar significance has not been observed for NFKB1 (Figures 1(b)–1(f)).